ANNUAL MEETING: SAVE THE DATE
|
|
The HIRN 2021 Annual Investigator Meeting will be held virtually
Tuesday, September 21 – Thursday, September 23, 2021
from 12:00 – 5:00 pm Eastern.
|
|
IMAGES FOR THE HIRN WEBSITE |
|
We are updating the HIRN website and would like to display images from your projects! Please email us images to include on the website.
|
|
HIRN provides abundant examples of innovation, and this month highlights an imaging innovation from the lab of investigator Galya Orr (CBDS consortium), who first described the approach called “fliFISH” and has followed up with another recent paper describing extended findings using this technology. fliFISH, or fluctuation localization imaging-based fluorescence in situ hybridization, is an improvement of single-molecule FISH to enable more precise spatial quantification of transcripts in single cells. fliFISH utilizes primary probes designed to hybridize to mRNA in the expected manner, but the secondary probes are comprised of photo-switching dye molecules instead of typical fluorescence molecules. The photo-switching dyes report through a photoblinking pattern that allows better resolution and quantification than traditional fluorescence intensity; this idea is derived from imaging techniques known as stochastic optical reconstruction microscopy (STORM) and photoactivated localization microscopy (PALM).
Compared to single-cell transcriptomics approaches such as single-cell RNA-sequencing, fliFISH has the advantage of spatial reference and more reliable detection at very low transcript levels. The spatial reference benefit is reiterated in the recent paper, in which Orr’s group and Sussel’s group employed fliFISH to examine four genes and showed that their heterogeneous expression in beta cells mapped to a radial pattern in intact islets; beta cells having highest expression were closer to the center of islets while beta cells having the lowest expression (perhaps the more immature beta cells) were at the periphery. Altogether, fliFISH is a wonderful complementary technology that should certainly see more application for questions where gene expression needs to be related to spatial context.
Click HERE to access the resource paper
Contact us with a scientific highlight to profile in the newsletter
|
|
THE SUGAR SCIENCE SEMINAR SERIES
|
|
the(sugar)science with Drs. Douglas Melton (Harvard) and Mark Atkinson (Univ. Florida) have assembled a new scientific series "State of the Science". It is an interactive conversation between global thought leaders in the field of type 1 diabetes, early career researchers, and clinicians. The dialogue will promote fresh debate about the state of T1D science. Learn more HERE.
|
|
CIHR-INMD and NIH NIDDK Symposium
To celebrate the 100th anniversary of the discovery of insulin in 2021, The NIDDK and Canadian Institute of Health Research (CIHR) are hosting a special Diabetes Symposium "Heterogeneity of Diabetes: Beta Cells, Phenotypes and Precision Medicine" online. This symposium will capitalize on diabetes research excellence and bring together research leaders to tackle the challenges and opportunities presented by investigation of the heterogeneity of diabetes and to inform the next steps for research in this area. Register HERE by June 3, 2021.
|
|
dkNET Webinar
The dkNET (NIDDK Information Network) is inviting you to join them for a webinar "Appyters: Turning Jupyter Notebooks Into Data-Driven Web Apps." Jupyter Notebooks have transformed the communication of data analysis pipelines by facilitating a modular structure that brings together code, markdown text, and interactive visualizations. Here, we extended Jupyter Notebooks to broaden their accessibility with Appyters. Here, we extended Jupyter Notebooks to broaden their accessibility with Appyters. Appyters turn Jupyter Notebooks into fully functional standalone web-based bioinformatics applications.
Dr. Avi Ma'ayan, Mount Sinai Endowed Professor in Bioinformatics, Professor in Department of Pharmacological Sciences, and Director of Mount Sinai Center of Bioinformatics, Icahn School of Medicine at Mount Sinai, will be presenting on Friday, May 28, 2021, 11 am - 12:00 pm PDT. Register HERE.
|
|
Diabetes Research Centers Virtual Seminar Series
To address the disruption in seminars & scientific interactions at the onset of the Covid-19 pandemic, nine NIDDK-sponsored Diabetes Research Centers (DRCs) and three Centers for Diabetes Translational Research (CDTRs) established a weekly Virtual Seminar series. The series has been well-received and will continue. Anyone can register for the seminars, which are free and open to the public (registration required).
Dr. Darleen Sandoval from the University of Colorado will be presenting on June 9, 2021 at 1:00 pm CT. “Lessons from mouse models of bariatric surgery.”
|
|
18th Immunology of Diabetes Society Congress
The Immunology of Diabetes Society (IDS) is dedicated to improving our understanding of the pathogenesis and treatment of type 1 diabetes. We invite you to the 18th IDS Congress which will be an in-person meeting in Nashville, TN, USA, on October 29th – November 1st, 2021. For more information and registration visit HERE.
|
|
RFA-DK-21-005: Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
- Application due date: June 22, 2021
RFA-DK-21-006: Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
- Application due date: September 20, 2021
PAR-20-140: Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
-
Application due date: Standard dates apply
- Foreign applications are allowed
F31 PAR-19-378: Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases
-
Application due date: Standard dates apply
- Foreign applications allowed
F32 PAR-19-379: Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases
-
Application due date: Standard dates apply
- Foreign applications allowed
|
|
Below is a summary of the most recent job postings by category (Faculty, Research Staff/Admin, Postdoc). Visit the HIRN Website for a full listing for job opportunities.
|
|
Director
The American Diabetes Association is seeking a Vice President of Research & Science to join our Science & Health Care Team. Reporting to the Chief Science and Medical Officer, the Vice President will be responsible for management of the ADA’s research portfolio and the execution of the annual ADA Scientific Sessions. This leader will be expected to have diabetes content mastery and research experience. It is required that this individual possess a strong science background, have grant experience, meeting management skills, strong knowledge of budget management and fiscal responsibility, possess strong organization skills, and have an innovative mindset. This leader will need to proactively identify content area needs and budgetary matters and communicate them effectively with the Chief Medical & Science Officer or the VP of Operations. Please visit the site HERE.
|
|
Director
JDRF has a Director position that requires the skills, vision, and desire to explore and implement novel approaches that will accelerate research and development leading to curative and preventive therapies for T1D. The successful candidate can look forward to interesting and challenging work by building strong relationships with fellow staff and a network of volunteers that will have a meaningful impact on the lives of everyone affected by T1D. The ideal applicant will have a strong background in immunology, pharmacology, cell biology or endocrinology in the context of diabetes, autoimmune or metabolic diseases, and have demonstrated capabilities in translating discoveries into therapeutic concepts or products. Please visit the site HERE.
|
|
Program Director for Integrative Physiology of Human Diabetes
The National Institute of Diabetes and Digestive and Kidney Diseases is hiring a Program Director for Integrative Physiology of Human Diabetes. A scientist with strong managerial, communications and interpersonal skills, and experience in integrative physiology relevant to diabetes, is sought for the position of Program Director for Integrative Physiology in the Division of Diabetes, Endocrinology, and Metabolic Diseases (DDEMD) in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), at the National Institutes of Health. Research to be managed by the Director of DDEMD’s Integrative Physiology program is supported through multiple mechanisms, including regular research grants and cooperative agreements. Activities to be pursued include planning, establishing, and overseeing a wide range of goal-directed initiatives to expedite and enhance translational, pre-clinical and clinical research in diabetes. Apply HERE.
|
|
Program Director for Diabetes Behavioral Science
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is seeking a clinical behavioral scientist to serve as Program Director for Diabetes Behavioral Science. The Program Director will play an active role in stimulating new research and managing ongoing grant portfolios focused on understanding the interaction between behavioral, psychological, and biological factors to inform development of more effective and targeted interventions to prevent and treat diabetes.
|
|
Program Director for Health Equity in Diabetes
|
|
Program Officials
The National Institute of Diabetes and Digestive and Kidney Diseases is hiring program officials with expertise in translational research in any of the following four topic areas as they specifically relate to key questions in diabetes, endocrine or metabolic diseases:
· Integrative physiology of human diabetes, including physiology of counter-regulatory responses to hypoglycemia, mechanisms involved in regulation of peripheral metabolism, autonomic nervous system regulation of glucose and lipid metabolism, and basic and clinical studies investigating effects of bariatric surgery on diabetes and diabetes-related outcomes;
· Neuroscience of human behavior and behavior change, including brain and peripheral systems that impact the onset, severity or resolution of diabetes or obesity pathophysiology;
· Immune regulation and inflammation, including innate and adaptive immune mechanisms influencing peripheral insulin resistance in animal models and humans;
· Precision medicine in diabetes and obesity.
The mission of the Division of Diabetes, Endocrinology and Metabolic Diseases is to support broad-based research programs focused on both basic and clinical research in the areas of type 1 and type 2 diabetes and other metabolic diseases. Apply Here
|
|
Research Scientist
The University of Chicago beta cell/diabetes research group under the direction of Dr. Raghu Mirmira has funded openings for several postdoctoral research scientists with interest in applying/learning cell biological techniques (immunoprecipitation, immunohistochemistry, confocal imaging), mouse genetic skills, human islet biology, and immunology and inflammation research. NIH-funded research projects in the Mirmira laboratory include the study of beta cell development and function, human islet gene regulation and mRNA translation, and islet cytokine signaling in the context of type 1 diabetes. Please send your CV, cover letter, and contact information with 3 references to Dr. Mirmira.
|
|
dkNET Community Liaison
The NIDDK Information Network has an open position for a Community Liaison to provide community outreach and lead engagement with the scientific community. This position will support a range of activities linked to community-dkNET partnerships, researcher engagement and knowledge networking. The position will entail engaging with research scientists, students and trainees, government, industry and broader audiences through workshops, in-person outreach events, multimedia, social media and Web-based systems. dkNET was launched by the FAIR Data Informatics Laboratory at the University of California, San Diego to serve the needs of basic and clinical investigators in diabetes, digestive and kidney disease by addressing the challenge of connecting researchers to research resources, assisting researchers with rigor and reproducibility guidelines, supporting researchers in navigating new data sharing requirements, and providing tools in enabling data discovery and hypothesis generation. More information click HERE.
|
|
Postdoctoral Position
The Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope is looking for a talented postdoctoral fellow. The collaborative laboratories of Drs. John Kaddis and Bart Roep are jointly seeking innovative postdoctoral candidates to conduct in-silico translational research in the field of type 1 diabetes (T1D). This individual will participate in one or more projects that examine the role of molecular, cellular, genetic, and epidemiological variation in T1D. This candidate will have an opportunity to work with specialists in the fields of immunology, diabetes, and data/computer science. Expertize in statistical methods for disease risk prediction and modeling, as well as clinical data, genome sequence, SNP array, “-omics”, and large-scale genetic association analysis is helpful. Experience with public databases/repositories is highly desired. Necessary skills include those from bioinformatics, computer/data science, mathematics, software engineering, and computational biology. Please send your CV, cover letter, and contact information with 3 references to Dr.Kaddis.
|
|
Postdoctoral Position
The Indiana Biosciences Research Institute (IBRI) Diabetes Center has a postdoctoral position available. We are looking for highly motivated researcher to join the IBRI in the lab of Dr. Decio Eizirik. This lab aims to clarify the mechanisms of pancreatic beta cell dysfunction and death in type 1 diabetes mellitus, with focus on endoplasmic reticulum stress, alternative splicing and other mechanisms that may contribute to beta cell death and generation of neoantigens. The selected candidate will participate in a team working with primary human and iPSC-derived islets, animal models of diabetes and human beta cell lines, and advanced molecular biology techniques. Interested applicants should send a letter/statement of interests, CV, and contact information for 2-3 references to Dr. Eizirik.
|
|
Postdoctoral Position
A postdoctoral position is available in the group of Dr. Remi Creusot at the Columbia Center for Translational Immunology (CCTI), to participate in research investigating the pathophysiology and therapy of autoimmune diabetes. The research will focus primarily on two NIH-funded projects: one studying the development and function of autoreactive T cells in humanized mouse models and a collaborative project on engineered stromal cells to reestablish immune tolerance. Applicants should send a full CV, a one-page cover letter highlighting research interests and goals, and the name and contact details of 3 references directly to Dr. Creusot.
|
|
Postdoctoral Position
A postdoctoral position is available in the laboratory of Dr. Douglas Melton at Harvard University. We seek a creative and highly collaborative PhD scientist with computational skills in single cell RNA-seq and/or ATAC-seq analysis (Trajectory inference, Multimodal analysis, Noise modeling, Entropy analysis). Research projects in the Melton laboratory include the study of human pancreatic islet development and dysfunction in the context of type 1 diabetes, using pluripotent stem cell-derived islets as a human model system. Interested applicants are encouraged to send their CV and names of 3 references to Dr.Pop.
|
|
Postdoctoral Position
Applications are invited for a Postdoctoral Fellow at the intersection of Regulatory Genomics and Statistical Genetics in the laboratory of Dr. Steve Parker in the Departments of Computational Medicine & Bioinformatics and Human Genetics at the University of Michigan Medical School. The major goal of the lab is to generate mechanistic knowledge about how disease susceptibility is encoded in the non-coding portion of the genome (from GWAS), with a focus on diabetes and related traits. For more information, please visit the Parker laboratory website.
|
|
Postdoctoral Position
The Wagner lab at the Broad Institute is looking for an energetic researcher interested in studying the role of ubiquitination in beta-cell apoptosis. We use techniques in basic biology, chemical biology, high-throughput screening, and many other areas. It’s a great opportunity to learn about cutting-edge technologies while studying an exciting emerging area in beta-cell biology. Candidates should have a strong record of productivity and publication in islet biology or chemical biology. Interested applicants should send a letter, CV, and contact information for 2-4 references to Dr. Wagner.
|
|
Postdoctoral Position
The Montreal Diabetes Research Center at the University of Montreal, has two Postdoctoral positions available at the Rutter laboratory. The laboratory studies pancreatic beta cell biology and its perturbations in type 2 diabetes (Rutter et alDiabetologia, 63(10):1990-1998. doi: 10.1007/s00125-020-05205-5, 2020). The objectives of the two projects are to explore the role and regulation of interactions between beta cells within the pancreatic islet using live cell imaging and optogenetics (Project 1), and to understand how genomic variants associated with type 2 diabetes impact pancreatic beta cell function (Project 2). The successful applicants will hold a PhD or equivalent. Experience in islet biology and/or glucose homeostasis, calcium signaling and image analysis (Project 1) or CRISPR/Cas9 genome editing, culture of human-derived beta cells or directed differentiation of embryonic stem cells towards a beta cell fate would be advantageous. Candidates with experience in data analysis using R, MATLAB etc. are particularly welcome to apply. Please send a cover letter and curriculum vitae, including three references, to Dr. Rutter.
|
|
Postdoctoral Position
A postdoctoral position is available in the Lab of Dr. Sangeeta Dhawan at the Beckman Research Institute at City of Hope, in Los Angeles county, CA to study pancreatic beta cell development and maturation. The candidate should have a PhD in molecular, cell, or developmental biology. Experience in genetic mouse models, islet biology, physiology, molecular biology, high throughput sequencing is desirable. The candidate should send a cover letter/statement of research interests, CV, and contact information for three references directly to Dr. Dhawan.
|
|
Postdoctoral Position
The University of California, San Francisco are looking for recent PhD to pursue a career in science and biotechnology around modulation of immune cells to recognize and eliminate senescent cells. Senescent cells accumulate in many age related disease and in autoimmunity by evading immune surveillance. We are developing methods to tune the immune response to selectively eliminate senescent cells in a number of diseases associated with aging. People trained in my lab pursue careers in academia, biotech, venture funds or consultants for large firms. Some lab members take key technologies from the lab to begin start up companies. Please send cover letter and CV/resume to Dr.Bhushan.
|
|
Postdoctoral Position
The laboratory of Dr. Amelia Linnemann at the Indiana University Diabetes Center has an opening for a PhD and/or MD postdoctoral research scientist with skills in cell/molecular biological techniques (immunoprecipitation, western blotting, cloning) and/or microscopy. Research projects in the Linnemann laboratory include the study of pancreatic islet dysfunction and cytokine signaling in the context of type 1 and type 2 diabetes, with a focus on autophagy and the antioxidant response. Interested applicants are encouraged to send an updated CV and names of 3 references to Dr. Linnemann.
|
|
Postdoctoral Position
Pacific Northwest National Laboratory has a postdoctoral position available to join their multi-disciplinary team focused on mass spectrometry (MS) based omics analyses. This project is part of the Human Islet Research Network funded by the National Institute of Health. We are investigating the roles of alternative splicing in beta cell stress and development of type 1 diabetes. Interested candidates please send your CV, cover letter, and contact information with 3 references to Dr. Nakayasu.
|
|
Postdoctoral Position
The University of Florida under the Stabler laboratory is seeking a creative and dedicated postdoctoral associate to join their team in working on translational research in Type 1 diabetes. The research goals for this position are in the translation of our bioactive scaffolds and coatings into preclinical models for validation and optimization. As a highly collaborative laboratory, the Associate will integrate as a part of our team, working together with members of the laboratory, as well as our extensive researcher network. The Associate will be expected to take a leadership role in the laboratory, directing research goals and timelines, mentoring students, and writing reports and publications. Interested candidates should submit a CV, a summary of future research interests and goals, and three references to Dr. Stabler.
|
|
Postdoctoral Position
A postdoctoral research associate position is available in the Hughes Lab at the Washington University School of Medicine to study primary cilia in islet cells. The laboratory combines standard molecular and cell biology with advanced imaging techniques to explore novel roles of cilia in mouse and human islets. We have generated new cilia knockout mouse models with strong diabetic phenotypes and are looking for someone to lead the investigation of cilia-mediated signaling mechanisms in islet hormone secretion. For human studies, we have a funded project to image primary cilia in T1D pancreas which will generate important and clinically relevant findings in autoimmune diabetes. Interested candidates please email Dr. Jing Hughes. Please send your CV, cover letter, and contact information with 3 references to Dr. Hughes.
|
|
Postdoctoral Associate
The Long Lab is a translational immunology lab focused on better understanding underlying mechanisms of autoimmune disease, patient variability, and response to therapy. Currently, we are primarily focused on three, inter-related projects in the setting of T1D: 1) Causes and consequences of reduced response to IL-2, 2) Cellular definition and stability of CD8 T cell exhaustion associated with response to therapy, and 3) identification of biomarkers of disease severity. The Postdoctoral Research Associate conducts independent biomedical research relevant to defining mechanisms underlying CD8 T cell exhaustion in the context of type 1 diabetes (T1D). The Postdoctoral Research Associate is a team-player who welcomes challenges and wants to grow as a translational biologist. Requires a Ph.D. in Immunology or a related field and experience in tissue culture, cellular and molecular techniques. Please send your CV, cover letter, and contact information with 3 references to Dr. Long.
|
|
Postdoctoral Position
The Department of Molecular & Medical Genetics at Oregon Health & Science University (OHSU) in Portland, Oregon, is seeking a highly motivated and enthusiastic post-doctoral fellow to study adeno-associated virus (AAV) and its application for human gene therapy in the lab led by Professor Hiroyuki Nakai, M.D., Ph.D. Specifically, the lab is looking for a post-doctoral researcher who can lead productively a newly funded multi-PI (MPI) NIH project ” U01DK123608 (MPIs: Nakai, Grompe and Kay): Gene Therapy for Diabetes, ” where we seek to develop clinically relevant novel AAV vectors and methods for in vivo regeneration of insulin-secreting beta cells in rhesus macaques and profoundly understand the mechanisms behind the technologies. The successful candidate will also contribute to the training of graduate, undergraduate, and high school students, as well as research staff. Please send a cover letter and C.V. to
|
|
Research Associate II
The Arrojo e Drigo laboratory at Vanderbilt University, has a research assistant II position open. This position requires knowledge of laboratory procedures, record keeping, validated experience in animal handling and anatomy, animal colony management, and standard molecular biology procedures. The research assistant II will support ongoing experiments in animal procedures, molecular biology, cell culture and microscopy. Motivated individuals will have their own projects and perform animal-related research. Additional responsibilities will include maintenance of and management of transgenic animal colonies and genotyping. Please send your CV, cover letter, and contact information with 3 references to
|
|
Subscribe to the newsletter |
|
Email us your newsletter suggestions |
|
|
|
|
|
|
|
